NURSING
Nursing: Neuroanatomy and Psychiatry Discussion Board Post
All depressive disorders are complex psychological, neurological functions that need to be understood well to be treated appropriately. Each person has different feelings, emotions, and thought processes that provide a wide range of cognitive abnormalities when depression occurs (Kaltenboeck & Harmer, 2018). The neuroscience of depression is therefore complicated in terms of interpretation.
Clinically, the neurotransmissions of the brain chemicals have to be discovered meaningfully before diagnosing a patient with the actual depressive disorder. Early methods of diagnosis included measurements of neurotransmitters, their precursors, or changes in plasma; however, now the methods have evolved, including brain imaging. The images have shown that depression occurs when decreased levels of serotonin transporter binding are observed within the middle of the brain and amygdala or alterations in serum, plasma, brain tissue and cerebrospinal fluid, etc.( Kaltenboeck & Harmer, 2018). Similarly, other complex forms need to be reported shrewdly since some patients intricate diagnoses. The structural abnormalities in neurological matters during depression are concerned with grey and white matter within the brain. In contrast, functional abnormalities reflect the disturbed task-related abnormal patterns that could be due to negatively affected blood flow in certain brain areas, such as different types of the cortex. It all comes down to the pathophysiological control of the cognitive network, salience network, node network, and affective network among depressed individuals.
The treatment of depression could be outlined well, as comorbidities of the patients need to be gauged with any possible long-term consequences on health. For example, if the physician straightaway prescribes a patient any anti-depressant, his hypertension or cardiovascular illness could bring unwanted repercussions, leading to an increased risk for depression or hyperactivity. The vulnerability factor for acute depression has to be reported for the affected individuals insightfully to make the treatment or intervention successful, considering the patients history, immune systems indicators, and inflammatory biomarkers thoroughly.
Reference
Kaltenboeck, A. & Harmer, C. (2018). The neuroscience of depressive disorders: A brief review of the past and some considerations about the future. Brain and Neuroscience Advances, 2. https://doi.org/10.1177/2398212818799269
